Woonyoung Choi
Johns Hopkins University
H-index: 36
North America-United States
Top articles of Woonyoung Choi
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis
Cell Reports
2024/5/28
Ziqiao Wang
H-Index: 8
Hui Yao
H-Index: 17
Woonyoung Choi
H-Index: 26
Cathy Mendelsohn
H-Index: 27
Peng Wei
H-Index: 12
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined …
European urology
2024/4
Molecular subtyping and immunohistochemistry validation identifies muscle Invasive bladder cancer subgroups with poorer overall survival
Cancer Research
2024/3/22
Molecular profile of bladder cancer progression to clinically aggressive subtypes
2024/2/6
Woonyoung Choi
H-Index: 26
Peng Wei
H-Index: 12
Predicting clinical outcomes in the S1314-COXEN trial using a multimodal deep learning model integrating histopathology, cell types, and gene expression.
2024/2/1
Tumour tissue‐derived small extracellular vesicles reflect molecular subtypes of bladder cancer
Journal of Extracellular Vesicles
2024/2
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Clinical Cancer Research
2024/1/17
Woonyoung Choi
H-Index: 26
Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer
European urology
2024/1
Identification of lineage-specific transcriptional factor–defined molecular subtypes in small cell bladder cancer
European urology
2023/6/27
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small‐cell carcinoma of the bladder
Archives of Breast Cancer
2014/5/31
A phase 1 trial of durvalumab in combination with Bacillus Calmette-Guerin (BCG) or external beam radiation therapy in patients with BCG-unresponsive non-muscle-invasive …
European urology
2023/6/1
Control of the Basal Molecular Subtype of Murine Bladder Cancer by Adaptive Immunity
Cancer Research
2023/4/4
Mingxiao Feng
H-Index: 5
Woonyoung Choi
H-Index: 26
MP14-16 LATE CELL CYCLE SIGNATURES STRATIFY GEMDOCE RESPONSES FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
The Journal of Urology
2023/4
Andrew Gabrielson
H-Index: 11
Mingxiao Feng
H-Index: 5
Sunil Patel
H-Index: 1
Max Kates
H-Index: 26
Woonyoung Choi
H-Index: 26
Atezolizumab with platinum and etoposide chemotherapy followed by cystectomy for patients with localized small cell neuroendocrine bladder cancer.
2023/2/20
Woonyoung Choi
H-Index: 26
Nirmish Singla
H-Index: 19
Identification of lineage-specific transcription factor defined subtypes in small cell/neuroendocrine bladder cancer.
Gastroenterology
2020/5/1
Combined Mek inhibition and Pparg activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis
bioRxiv
2023
Woonyoung Choi
H-Index: 26
Chao Lu
H-Index: 15
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients
Urologic Oncology: Seminars and Original Investigations
2022/9/1
Woonyoung Choi
H-Index: 26
Association of DNA damage response (DDR) gene mutations (mts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients …
2022/6/1
Woonyoung Choi
H-Index: 26
S1314 correlative analysis of ATM, RB1, ERCC2, and FANCC mutations and pathologic complete response (pT0) at cystectomy after neoadjuvant chemotherapy (NAC) in patients with …
2022/6/1
Woonyoung Choi
H-Index: 26
Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance).
2022/6/1
